Severe bleeding after antithrombotic therapy in urosepsis masquerading as myocardial infarction

0Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Cardiac dysfunction is common in patients with severe sepsis and septic shock. We present a 71-year-old woman with Escherichia coli urosepsis and sepsis-induced myocardial injury masquerading as non-ST elevated myocardial ischemia. Spontaneous psoas hematoma requiring blood transfusion and intracranial hemorrhage developed after antiplatelet and anticoagulant therapies, even in therapeutic doses. The patient was managed conservatively and recovered well with minor residual hemiparesis. Bleeding complications are a common risk of antithrombotic therapy. It is therefore crucial to weigh the impact of efficacy against safety. Old age, female gender, renal insufficiency and sepsis character increased the risk of bleeding in this patient. A misinterpretation of elevated cardiac troponin I may give rise to a diagnostic dilemma and cause unnecessary morbidity. © 2011 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Cheng, K. W., Shih, H. C., How, C. K., Lin, Y. Y., Yen, D. H. T., & Huang, M. S. (2011). Severe bleeding after antithrombotic therapy in urosepsis masquerading as myocardial infarction. Internal Medicine, 50(7), 779–782. https://doi.org/10.2169/internalmedicine.50.4681

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free